You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Bulking agents, antispasmodics and antidepressants for the treatment of irritable bowel syndrome
|
|---|---|
| Published in |
Cochrane database of systematic reviews, August 2011
|
| DOI | 10.1002/14651858.cd003460.pub3 |
| Pubmed ID | |
| Authors |
Lisa Ruepert, A Otto Quartero, Niek J de Wit, Geert J van der Heijden, Gregory Rubin, Jean WM Muris |
| Abstract |
Irritable bowel syndrome (IBS) is a common chronic gastrointestinal disorder. The role of pharmacotherapy for IBS is limited and focused mainly on symptom control. |
X Demographics
The data shown below were collected from the profiles of 14 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 4 | 29% |
| Japan | 2 | 14% |
| Romania | 1 | 7% |
| India | 1 | 7% |
| Unknown | 6 | 43% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 11 | 79% |
| Practitioners (doctors, other healthcare professionals) | 3 | 21% |
Mendeley readers
The data shown below were compiled from readership statistics for 413 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 3 | <1% |
| Australia | 2 | <1% |
| Germany | 1 | <1% |
| India | 1 | <1% |
| United Kingdom | 1 | <1% |
| Netherlands | 1 | <1% |
| Denmark | 1 | <1% |
| Peru | 1 | <1% |
| Greece | 1 | <1% |
| Other | 1 | <1% |
| Unknown | 400 | 97% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Bachelor | 77 | 19% |
| Student > Master | 53 | 13% |
| Researcher | 42 | 10% |
| Student > Ph. D. Student | 34 | 8% |
| Student > Postgraduate | 29 | 7% |
| Other | 89 | 22% |
| Unknown | 89 | 22% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 168 | 41% |
| Nursing and Health Professions | 29 | 7% |
| Psychology | 22 | 5% |
| Pharmacology, Toxicology and Pharmaceutical Science | 21 | 5% |
| Agricultural and Biological Sciences | 18 | 4% |
| Other | 47 | 11% |
| Unknown | 108 | 26% |
Attention Score in Context
This research output has an Altmetric Attention Score of 26. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 03 November 2023.
All research outputs
#1,513,464
of 25,711,518 outputs
Outputs from Cochrane database of systematic reviews
#3,213
of 13,134 outputs
Outputs of similar age
#6,585
of 132,313 outputs
Outputs of similar age from Cochrane database of systematic reviews
#19
of 109 outputs
Altmetric has tracked 25,711,518 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 94th percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 13,134 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 35.7. This one has done well, scoring higher than 75% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 132,313 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 95% of its contemporaries.
We're also able to compare this research output to 109 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 82% of its contemporaries.